Clinical trials
Recruiting Phase 3 trials in Colombia
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
100 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2016 | 1 |
| 2018 | 2 |
| 2019 | 1 |
| 2021 | 2 |
| 2022 | 5 |
| 2023 | 14 |
| 2024 | 22 |
| 2025 | 36 |
| 2026 | 17 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Recruiting | 100 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Merck Sharp & Dohme LLC | 26 |
| AstraZeneca | 12 |
| Novartis Pharmaceuticals | 10 |
| Hoffmann-La Roche | 5 |
| Amgen | 4 |
| Boehringer Ingelheim | 4 |
| Bristol-Myers Squibb | 4 |
| Novo Nordisk A/S | 3 |
| Intra-Cellular Therapies, Inc. | 2 |
| Takeda | 2 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Carcinoma, Non-Small-Cell Lung | 14 |
| Breast Neoplasms | 6 |
| Heart Failure | 4 |
| Schizophrenia | 4 |
| COVID-19 | 3 |
| Cardiovascular Diseases | 3 |
| Hypertension | 3 |
| Neoplasms | 3 |
| Obesity | 3 |
| Polyradiculoneuropathy, Chronic Inflammatory Demyelinating | 3 |
Trials
Showing 1 to 25 of 100. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.